Plant extracts have been used in African folk medicine to treat a wide array of infections, especially in Nigeria, for centuries. This article considers the potential medicinal uses and efficacy of the flavonoids epigallocatechin and epicatechin, which can be extracted from the Spondias mombin plant.
Compounds such as saponin, alkaloids, polyphenols, glycosides and terpenes are present in Spondias mombin extracts. Epigallocatechin and epicatechin are flavonoids that are part of the polyphenol group. They were found in the Spondias mombin medicinal plant for the first time through isolation of active components but are also major constituents of tea, fruits and chocolate. Epigallocatechin and epicatechin have been extensively researched for their diverse actions on human health and as therapeutic agents in the treatment of various human infections, especially resistant emerging and re-emerging infections. They are potent antioxidants, with antiviral, antimalarial and anticarcinogenetic properties, among others. Frequent consumption of epigallocatechin and epicatechin has been proven to have health benefits.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
They exhibit a promising future as a drug formulation that is cost-effective, highly biocompatible, and with low toxicity. Spondias mombin is a fructiferous tree found in Nigeria, Brazil and several other tropical forests in the world. This plant is common in the south-west of Nigeria (Yoruba region) and is commonly used in folk medicine. Various cultures maintain it in their collection of traditional medicine substances. Spondias mombin belongs to the family Anacardiacae; it grows in rainforest and coastal areas and can reach a height of 15-22m. The trunk has deep incisions in the bark that often produce a brown resinous substance. The leaves and flowers are at the end of the branches. Before the tree starts to flower, it strips itself of most of its leaves. The fruit, a 4cm-long oval yellow plum, has a leathery skin and a thin layer of fruit pulp with an exotic taste. It hangs in numerous clusters of more than a dozen on the tree. Very rich in vitamins B1 and C, the fruit mostly exists as an oval seed.1
Diverse health benefits
Epicatechin is a type of flavonoid which is mainly found in Spondias mombin green tea (Camellia sinensis) and dark chocolate. Polyphenols constitute 30-40% of the extractable solids from the dried stem bark. The main catechins present are epicatechin, and epigallocatechin.2 Epicatechins have proven diverse benefits to human health, reducing the risks of diabetes mellitus and cardiovascular diseases. Their pharmacological effects are anti-hyperlipidaemic, anti-inflammatory, antioxidative, anticarcinogenic, and cytoprotective. These flavonoids can be used as therapeutic agents individually or in combination with other synthetic drugs and antibiotics to produce a new generation of phytopharmaceuticals.
Epigallocatechin (EGC) is the most abundant, potent polyphenol and is responsible for most of the therapeutic benefits (either clinical, animal or cell culture studies) of Spondias mombin. It has various medicinal potentialities which include antimicrobial properties against resistant microorganisms, where it acts by either disrupting the cell membrane, inhibiting the biosynthesis of the cell constituents, disrupting cell signalling, or damaging DNA. Its most important antioxidant property is crucial in treating chronic diseases related to oxidative stress, cardiovascular, neurodegenerative diseases and cancer. Research on this property revealed information about its cardiovascular and antihypertensive activity, which enables EGC to prevent platelet aggregation, lower cholesterol and inhibit lipid peroxidation.3
In in-vitro studies using an albino rat model, EGC lowers the risk of cancer development by binding to various key proteins, thus affecting the signalling pathways, followed by growth inhibition due to apoptosis or suppression of angiogenesis and metastasis.4 EGC can also slow brain ageing and other neurodegenerative diseases such as Alzheimer’s and Parkinson’s, as demonstrated in mouse model studies.5 It shows anti-hypercholesterolaemic (anti-obesity) activity and promotes weight loss through fat oxidation.6 Animal studies have demonstrated that EGC is an efficient agent in preventing the development of type 1 and 2 diabetes.7 EGC increases lysosomal acidification, and regulates autophagy and lipid clearance in the liver due to its anti-steatotic property.4 EGC, in a dose-dependent manner, shows an anti-inflammatory property by reducing the release of cytokines/chemokines responsible for inflammation.8 Its anti-allergic property strongly inhibits activation of mast cells and expression of high-affinity IgE receptor.9
Antioxidative effects
Epicatechins are effective scavengers of free radicals such as reactive oxygen and nitrogen species and superoxide. In a study on the effect of Spondias mombin extract in intoxication of the liver, the extract scavenged free radicals and protected the liver from oxidative stress that would have brought about hepatic carcinogenesis.10 Epicatechin and other polyphenols decrease the susceptibility of low-density lipoprotein to oxidation, which prevents the initiation of artherosclerosis.11 HIV proteins Tat and gp 120 are known to cause neurotoxicity in humans via mechanisms that activate macrophages and glial cells and, finally, oxidative stress. Epicatechins are neuroprotective because they block the neurotoxic effects of the HIV proteins that cause oxidative stress.10 Pre-treatment with epicatechin prior to exposure of gamma radiation prevents hepatic and testicular damage. Damage would be due to oxidative stresses produced by the formation of free radicals as a result of radiation. Epicatechin is radioprotective, especially to patients undergoing radiotherapy.11
Hepatitis C virus (HCV) is an RNA virus that chronically infects about 160 million individuals. It is a member of the Flaviviridae family and is associated with life-threatening diseases like cirrhosis, liver failure and hepatocellular carcinoma.12 HCV infection can be spread via cell-to-cell transmission. Entry of virus is a multistep process which involves endocytosis and fusion of the viral membrane with the host membrane. EGC can prevent this cell-to-cell transmission due to its unique ability to inhibit the attachment of HCV and its entry into the host cell by impairment of virus binding to the cell, thereby preventing its RNA replication. Moreover, a single-dose concentration of EGC ranging from 50-1,600mg is sufficient to inhibit HCV and is safe for human volunteers.13 It is responsible for increasing the lipid droplet formation and impairment of lipoprotein secretion in hepatocytes, both of which are crucial for the life cycle of HCV.14
EGC affects each step of the HIV life cycle, from cell attachment, virus entry, replication cycle, to the expression of mRNA. It also interferes with RIGHT: Epigallocatechin virus infectivity by binding to the surface of the viral envelope and deforming the phospholipids, followed by lysis of the virus particle.15 The attachment of the gp120 envelope protein to the CD4 receptor on T-helper cells initiates the entry of HIV-1 into the host. EGC blocks the interaction of gp120 and CD4 and prevents the attachment of HIV-1 virions.16 This catechin inhibits reverse transcriptase (RT), which catalyses the conversion of RNA into DNA and integrase enzyme, which splice synthesised DNA into the host cell genome.15 EGC also inhibits viral production from infected cells and the level of expression of viral mRNA; it was able to alter the physical integrity and agglutinate the virus, preventing them from adsorbing on Madin-Darby Canine Kidney (MDCK) cells.17 It also ceased the growth of influenza virus by inhibiting the acidification of intracellular compartments like endosomes, lysosomes, etc, and inhibited entry by binding to haemagglutinin.18
Another virus against which EGC exerts activity is the adenovirus, a non-enveloped virus composed of a nucleocapsid and a double-stranded linear DNA genome. Approximately 5-10% of upper respiratory infections in children are caused by this organism. Weber and co-workers concluded that EGC inactivated adenoviruses and inhibited the viral protease activity.18 It was found to be most effective during the transition from early to late phase of the infection and also inhibited the late stages of viral infection followed by its intracellular growth.18
In conclusion, epigallocatechin and epicatechin are proven to be nature’s extraordinary therapeutic agents. More time and attention should be spent on developing them as a sustainable drug for the prophylaxis and treatment of complications and diseases.
References
Brown J, Arthur, J. Selenium, selenoproteins and human health: a review. Public Health Nutrition. 2001. (2B): 593-9.
Nakayam M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antivir Res. 1993;21:289-299.
Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N, Terasawa K, Ochiai H. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol. 2002;46:491-494.
El-Beshbishy HA. Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen- induced liver injury in rats. J Biochem Mol Biol. 2005;38(5):563-570.
Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antivir Res 2005;68:66-74.
Springbob K, Springbob K, Toni M. Introduction to the different classes of natural products. In Lanzotti, Virginia. 2009. Plant-derived Natural Products: Synthesis, Function and Application. Springer. P.3. ISBN 9780387854977.
Osakabe N, Babab S, Yasuda A, Iwamoto T, Kamiyama M, Takahisa T, Kondo K. Dose-response study of daily cocoa intake on the oxidative susceptibility of low-density lipoprotein in healthy human volunteers. J Health Sci. 2004;50(6):679-684
Nath S, Bachani M, Harshavardhana D, Steiner JP. Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway. J Neurovirol .2012; DOI 10.1007/s13365-012-0122-1.
Huang Q, Wu LJ, Tashiro SI, Onodera S, Ikejima T. Elevated levels of DNA repair enzymes and antioxidative enzymes by (1)-catechin in murine microglia cells after oxidative stress. J Asian Nat Prod Res. 2006;8:61-71.
Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011:17:107-115.
Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V et al. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology. 2012;55:720- 9.
Li L, Stillemark-Billton P, Beck C, Bostrom P, Andersson L, Rutberg M et al. Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL. J Lipid Res. 2006;47:67-77.
Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 2002;53:19-34.
Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol. 2003;112:951-957.
Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993;21:289-299.
Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol. 2002;46:491-494.
Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 2003;58:167-173.
Author biographies
ADEYINKA T AINA is Innovation Fellow at the Pharmaceutical Manufacturing Technology Centre, University of Limerick. He has extensive research experience in pharmaceutical and biomedical applications. He did his doctoral training at the Laboratory of Biophysics and Surface Analysis at the School of Pharmacy, University of Nottingham.
OLUMIDE K INYANG is a graduate research fellow at the Centre for Biocomputing and Drug Development in Adekunle Ajasin University, Nigeria, where he recently completed his BSc degree in Biochemistry. He is interested in cancer therapeutics by deploying molecular biology and biocomputational tools.
OGUNLEYE ADEWALE JOSEPH is a graduate research fellow at the Centre for Biocomputing and Drug Development in Adekunle Ajasin University, Nigeria, where he recently completed his BSc degree in Microbiology. He majors in addressing health challenges posed by infectious agents by deploying molecular biology and bio-computational tools.
OSUNTOKUN OLUDARE TEMITOPE is a lecturer/ researcher in the Department of Microbiology, Adekunle Ajasin University, Nigeria. He holds a PhD in Phyto-medicine, Pharmaceutical/Medical Microbiology from Obafemi Awolowo University, Nigeria. Dr Temitope is an editor for various journals and Editor-in-Chief of Advances in Cytology & Pathology.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.